Tech Company Financing Transactions
Green Biologics Funding Round
Green Biologics closed a $25 million Series B funding round on 12/5/2013. Investors included Sofinnova Ventures and Morgan Joseph TriArtisan.
Transaction Overview
Company Name
Announced On
12/5/2013
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Series B
Investors
Sofinnova Ventures (Lead Investor)
Morgan Joseph TriArtisan (Gene Ramirez)
Proceeds Purpose
The investment brought us new strategic and financial investors, and positions us well for future growth as we continue to build a global leader in renewable chemicals.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
154AH Brook Dr. Milton Park
Abingdon Oxfordshire, OX14 4SD
UK
Abingdon Oxfordshire, OX14 4SD
UK
Phone
Website
Email Address
Overview
Green Biologics Ltd. (GBL) is an industrial biotechnology company and a global leader in renewable n-butanol, acetone, and their derivatives.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Sean Sutcliffe
Chief Financial Officer
Steve Breach
Chief Technical Officer
Timothy Davies
Controller
Christina Sweeney
VP - Bus. Development
Patrick Simms
VP - Bus. Development
Timothy Staub
VP - Marketing
David Anderson
Browse more venture capital transactions:
Prev: 12/5/2013: EducationSuperHighway venture capital transaction
Next: 12/5/2013: Reset Therapeutics venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs